Literature DB >> 31962222

Fine particulate matter and cause-specific mortality in the Hong Kong elder patients with chronic kidney disease.

Jinjun Ran1, Shengzhi Sun2, Lefei Han3, Shi Zhao4, Dieyi Chen5, Fang Guo1, Jinhui Li1, Hong Qiu6, Yujie Lei7, Linwei Tian8.   

Abstract

Emerging epidemiologic studies suggested that particulate matter (PM) was a risk factor for the incidence of chronic kidney disease (CKD). However, few studies were conducted to examine whether PM was associated with cause-specific deaths in the CKD progression. This study aimed to estimate the association between fine particulate matter (PM2.5) and a spectrum of deaths among CKD patients. We took leverage of the Elderly Health Service cohort (n = 66,820), a large Hong Kong elderly cohort followed up till 2010. A total of 902 CKD incident patients in the cohort were identified during the follow-up period. We estimated yearly PM2.5 at the residential address for each CKD patient based on a satellite-based spatiotemporal model. We used Cox proportional hazards models with attained age as the underlying timescale to assess the association between long-term exposure to PM2.5 and cause-specific mortality among CKD patients. A total of 496 patients died during the follow-up, where 147 died from cardiovascular disease, 61 from respiratory disease and 154 from renal failure. The mortality hazard ratio (HR) per interquartile-range increase in PM2.5 (4.0 μg/m3) was 1.97 (95% confidence interval (CI): 1.34 to 2.91) for ischemic heart disease (IHD) among CKD patients, and was 1.42 (95%CI: 1.05 to 1.93) for CKD among those patients concomitantly with hypertension. Associations were not of statistical significance between PM2.5 and mortality hazard ratios of all-cause, stroke, and pneumonia among CKD patients. Our findings suggest that long-term exposure to PM2.5 may contribute to the CKD progression into ischemic heart diseases.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Cohort study; Fine particulate matter; Ischemic heart disease

Year:  2020        PMID: 31962222     DOI: 10.1016/j.chemosphere.2020.125913

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  7 in total

1.  Ambient Air Pollution and Mortality among Older Patients Initiating Maintenance Dialysis.

Authors:  Yijing Feng; Miranda R Jones; Nadia M Chu; Dorry L Segev; Mara McAdams-DeMarco
Journal:  Am J Nephrol       Date:  2021-03-31       Impact factor: 3.754

2.  Thermogravimetric analysis of soot combustion in the presence of ash and soluble organic fraction.

Authors:  Qian Zhang; Jia Fang; Zhongwei Meng; Chen Chen; Zihan Qin
Journal:  RSC Adv       Date:  2020-09-10       Impact factor: 4.036

3.  Association of short-term exposure to ambient PM2.5 with hospital admissions and 30-day readmissions in end-stage renal disease patients: population-based retrospective cohort study.

Authors:  Lauren H Wyatt; Yuzhi Xi; Abhijit Kshirsagar; Qian Di; Cavin Ward-Caviness; Timothy J Wade; Wayne E Cascio; Ana G Rappold
Journal:  BMJ Open       Date:  2020-12-15       Impact factor: 2.692

Review 4.  Environmental Pollution and Chronic Kidney Disease.

Authors:  Hui-Ju Tsai; Pei-Yu Wu; Jiun-Chi Huang; Szu-Chia Chen
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

Review 5.  Adverse Effects of fine particulate matter on human kidney functioning: a systematic review.

Authors:  Leen Rasking; Kenneth Vanbrabant; Hannelore Bové; Michelle Plusquin; Katrien De Vusser; Harry A Roels; Tim S Nawrot
Journal:  Environ Health       Date:  2022-02-08       Impact factor: 5.984

Review 6.  Health Effects of Long-Term Exposure to Ambient PM2.5 in Asia-Pacific: a Systematic Review of Cohort Studies.

Authors:  Zhengyu Yang; Rahini Mahendran; Pei Yu; Rongbin Xu; Wenhua Yu; Sugeesha Godellawattage; Shanshan Li; Yuming Guo
Journal:  Curr Environ Health Rep       Date:  2022-03-16

7.  Joint exposure to outdoor ambient air pollutants and incident chronic kidney disease: A prospective cohort study with 90,032 older adults.

Authors:  Hongyan Liu; Xian Shao; Xi Jiang; Xiaojie Liu; Pufei Bai; Yao Lin; Jiamian Chen; Fang Hou; Zhuang Cui; Yourui Zhang; Chunlan Lu; Hao Liu; Saijun Zhou; Pei Yu
Journal:  Front Public Health       Date:  2022-09-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.